‘An Arm and a Leg’: The insurance warrior’s battle plan

Health care — and how much it costs — is scary. But you're not alone with this stuff, and knowledge is power. "An Arm and a Leg" is a podcast about these issues, and its second season is co-produced by KHN.

Matthew Lientz was an engineer for Boeing for over 30 years. When he was diagnosed with a rare form of cancer, he needed surgery from an expert doctor in another state. Although the surgery was his only option, his insurance denied the claim. That's when his wife, Diane, contacted Laurie Todd, who calls herself the “Insurance Warrior.”

Together, the three of them made the case for Lientz’s life. Fourteen years later, the speeches they gave in a conference room full of executives are a master class in winning insurance appeals — and living to tell the tale.

Through this battle, Todd learned that taking on your health insurance provider often means going up against your employer. That’s because most large companies "self-insure."

And in this case, that employer was one of the biggest businesses in the world.

For the origin story of the “Insurance Warrior,” check out our previous episode.


"An Arm and a Leg" is a co-production of KHN and Public Road Productions.

To keep in touch with "An Arm and a Leg," subscribe to the newsletter. You can also follow the show on Facebook and Twitter. And if you've got stories to tell about the health care system, the producers would love to hear from you.

To hear all KHN podcasts, click here.

And subscribe to "An Arm and a Leg" on Spotify, Apple Podcasts, Stitcher, Pocket Casts, or wherever you listen to podcasts.

Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Tirzepatide beats semaglutide in lowering diabetes risk and cardiovascular events in obesity patients